714569-35-4

Upstream product

• 565460-56-2 methyl {(2R)-1-[(3,4-dichlorophenyl)sulfonyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetate 
• 565460-55-1 methyl {(2R)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetate 
• 1493-27-2 ortho-nitrofluorobenzene 
• 98-31-7 3,4-dichlorobenzenesulphonyl chloride 
• 714569-27-4 (3R)-4-[(3,4-dichlorophenyl)sulfonyl]-3-(2-hydroxyethyl)-3,4-dihydroquinoxalin-2(1H)-one 
• 714568-86-2 dimethyl (2-nitrophenyl)-L-aspartate 
• 714569-31-0 2-{(2R)-1-[(3,4-dichlorophenyl)sulfonyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}ethyl methanesulfonate 
• 10387-40-3 potassium thioacetate 

Relevant academic research and scientific papers

2-QUINOXALINONE DERIVATIVES AS BRADYKININ ANTAGONISTS AND NOVEL COMPOUNDS

2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.

NOVEL QUINOXALINONE DERIVATIVES AS BRADYKININ B1 ANTAGONISTS

2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.